Korean Guidelines for the Management of Dyslipidemia
The Korean Society of Lipid and Atherosclerosis (KSoLA) published its 5th Edition of the Korean Guidelines for the Management of Dyslipidemia in 2022.
Integrated Guidance for Enhancing the Care of Familial Hypercholesterolemia in Australia
The FH Australasia Network Consensus Working Group published its consensus statement titled "Integrated Guidance for Enhancing the Care of Familial Hypercholesterolemia in Australia." The NLA endorsed this consensus statement in August 2020.
IAS Releases Global Recommendations for the Management of Dyslipidemia
The International Atherosclerosis Society (IAS) has released its position paper "Global Recommendations for the Management of Dyslipidemia." The NLA Guidelines Task Force, led by Terry Jacobson, MD, provided extensive review and advice regarding the release of these guidelines.
IAS Panel for Global Recommendations for the Management of Dyslipidemia
Lipoprotein(a) as a Cardiovascular Risk Factor: Current Status
Read the statement from the European Society of Cardiology here
European Atherosclerosis Society (EAS) Consensus Postion Paper on the Polygenic Nature of Hypertriglyceridaemia: Implications for Definition, Diagnosis, and Management
Published in Lancet Diabetes & Endocrinology, free to download from January 31 – February 28, 2014 at http://www.thelancet.com/journals/landia/article/PIIS2213-8587(13)70191-8/fulltext
This page was last updated: Mar 25, 2024